Ameriprise’s Exponent EXPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.15M Sell
124,850
-55,888
-31% -$3.97M ﹤0.01% 2076
2025
Q4
$12.6M Sell
180,738
-571
-0.3% -$40.1K ﹤0.01% 1735
2025
Q3
$12.6M Sell
181,309
-101,601
-36% -$7.26M ﹤0.01% 1730
2025
Q2
$21.1M Buy
282,910
+8,398
+3% +$651K 0.01% 1319
2025
Q1
$22.3M Sell
274,512
-371,514
-58% -$32.4M 0.01% 1242
2024
Q4
$57.6M Buy
646,026
+44,002
+7% +$4.43M 0.01% 768
2024
Q3
$69.4M Buy
602,024
+85,450
+17% +$8.94M 0.02% 703
2024
Q2
$49.1M Sell
516,574
-663,379
-56% -$59.8M 0.01% 805
2024
Q1
$97.6M Buy
1,179,953
+79,863
+7% +$6.61M 0.03% 542
2023
Q4
$96.9M Buy
1,100,090
+406,831
+59% +$33.3M 0.03% 528
2023
Q3
$59.3M Buy
693,259
+71,074
+11% +$6.43M 0.02% 672
2023
Q2
$58.1M Buy
622,185
+57,029
+10% +$5.36M 0.02% 701
2023
Q1
$56.3M Buy
565,156
+247,075
+78% +$25.1M 0.02% 693
2022
Q4
$31.5M Sell
318,081
-244,955
-44% -$23.8M 0.01% 954
2022
Q3
$49.4M Sell
563,036
-176,696
-24% -$16.8M 0.02% 706
2022
Q2
$67.6M Sell
739,732
-93,045
-11% -$8.77M 0.02% 616
2022
Q1
$89.9M Sell
832,777
-91,845
-10% -$8.86M 0.03% 561
2021
Q4
$108M Sell
924,622
-517,911
-36% -$60.9M 0.03% 549
2021
Q3
$163M Sell
1,442,533
-75,392
-5% -$8.13M 0.05% 380
2021
Q2
$135M Sell
1,517,925
-116,721
-7% -$10.9M 0.04% 433
2021
Q1
$159M Buy
1,634,646
+130,919
+9% +$12.3M 0.05% 358
2020
Q4
$135M Sell
1,503,727
-114,410
-7% -$9.12M 0.05% 389
2020
Q3
$117M Buy
1,618,137
+151,266
+10% +$12M 0.05% 383
2020
Q2
$119M Buy
1,466,871
+120,385
+9% +$8.67M 0.05% 352
2020
Q1
$96.8M Buy
1,346,486
+158,638
+13% +$11.5M 0.05% 341
2019
Q4
$82M Buy
1,187,848
+25,787
+2% +$1.7M 0.03% 488
2019
Q3
$81.2M Sell
1,162,061
-114,380
-9% -$7.72M 0.04% 476
2019
Q2
$74.7M Buy
1,276,441
+104,050
+9% +$5.93M 0.03% 518
2019
Q1
$67.7M Sell
1,172,391
-217,010
-16% -$11.7M 0.03% 538
2018
Q4
$70.5M Buy
1,389,401
+527,353
+61% +$26.5M 0.04% 496
2018
Q3
$46.2M Buy
862,048
+85,605
+11% +$4.38M 0.02% 790
2018
Q2
$37.5M Buy
776,443
+43,213
+6% +$1.98M 0.02% 801
2018
Q1
$28.8M Buy
733,230
+241,440
+49% +$9.13M 0.01% 932
2017
Q4
$17.5M Buy
491,790
+37,302
+8% +$1.37M 0.01% 1165
2017
Q3
$16.8M Buy
454,488
+16,574
+4% +$547K 0.01% 1178
2017
Q2
$12.8M Buy
437,914
+16,422
+4% +$491K 0.01% 1349
2017
Q1
$12.6M Buy
421,492
+14,482
+4% +$422K 0.01% 1357
2016
Q4
$12.3M Buy
407,010
+2,928
+0.7% +$84.9K 0.01% 1358
2016
Q3
$10.3M Sell
404,082
-61,498
-13% -$1.6M 0.01% 1421
2016
Q2
$13.6M Buy
465,580
+8,702
+2% +$226K 0.01% 1163
2016
Q1
$11.7M Sell
456,878
-15,690
-3% -$379K 0.01% 1296
2015
Q4
$11.8M Buy
472,568
+181,714
+62% +$4.61M 0.01% 1322
2015
Q3
$6.48M Buy
290,854
+40,496
+16% +$891K ﹤0.01% 1809
2015
Q2
$5.61M Sell
250,358
-1,774
-0.7% -$39K ﹤0.01% 2070
2015
Q1
$5.61M Buy
252,132
+11,292
+5% +$242K ﹤0.01% 2033
2014
Q4
$4.97M Sell
240,840
-5,984
-2% -$116K ﹤0.01% 2062
2014
Q3
$4.37M Sell
246,824
-13,264
-5% -$244K ﹤0.01% 2110
2014
Q2
$4.82M Buy
260,088
+8,592
+3% +$153K ﹤0.01% 2103
2014
Q1
$4.72M Buy
251,496
+19,356
+8% +$357K ﹤0.01% 2063
2013
Q4
$4.5M Buy
232,140
+29,912
+15% +$565K ﹤0.01% 2047
2013
Q3
$3.63M Buy
202,228
+5,020
+3% +$83.7K ﹤0.01% 2136
2013
Q2
$2.92M Buy
+197,208
New +$2.71M ﹤0.01% 2183

Other funds holding EXPO

Ameriprise's EXPO Position: Q1 2026 in Review

Ameriprise reduced its Exponent (EXPO) stake by 31% in Q1 2026, selling an estimated $3.97M and leaving 124,850 shares worth $8.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2076.

Ameriprise first reported a position in EXPO in Q2 2013 and has held it in 52 quarters since. The position peaked at $163M in Q3 2021. 360 funds tracked by Wall St. Rank hold EXPO as of Q1 2026.

  • Ameriprise held 124,850 shares of Exponent worth $8.15M as of Q1 2026.
  • Ameriprise sold 55,888 Exponent shares in Q1 2026, an estimated $3.97M.
  • Exponent made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2076 holding.
  • Ameriprise first reported a position in Exponent in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's Exponent position peaked at $163M in Q3 2021.
  • 360 funds tracked by Wall St. Rank held Exponent as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.